Skip to main content

Table 2 Univariate and multivariate analysis of prognostic factors for progression-free survival and overall survival

From: Trastuzumab in advanced breast cancer – a decade of experience in Germany

Parameter Progression-free survival Overall survival
Univariate p Multivariate p Univariate p Multivariate p
Palliative cytotoxic pretreatment 0.00051 -- < 0.0001 --
Age >65 years -- -- 0.072 0.038
Metastases other than skeletal 0.0061 0.032 0.0041 0.016
Hormone-receptor negative -- -- 0.039 --
M0 at initial diagnosis 0.0071 0.0013 0.040 0.0046
  1. -- denotes p >0.1.